Albiglutide
Extension to Study 200952 to Evaluate the Long-term Safety, Tolerability and Pharmacodynamics of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus Subjects
GSK · Phase 4 · Terminated · Enrollment 8
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Albiglutide arm | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.